A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension-Reference-Cited by-同舟云学术

A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension

Published:2017-10 Issue:10 Volume:56 Page:849-856.e6
ISSN:0890-8567
Container-title:Journal of the American Academy of Child & Adolescent Psychiatry
language:en
Short-container-title:Journal of the American Academy of Child & Adolescent Psychiatry

Author:

Handen Benjamin L.,Anagnostou Evdokia,Aman Michael G.,Sanders Kevin B.,Chan James,Hollway Jill A.,Brian Jessica,Arnold L. Eugene,Capano Lucia,Williams Craig,Hellings Jessica A.,Butter Eric,Mankad Deepali,Tumuluru Rameshwari,Kettel Jessica,Newsom Cassandra R.,Peleg Naomi,Odrobina Dina,McAuliffe-Bellin Sarah,Marler Sarah,Wong Taylor,Wagner Alexis,Hadjiyannakis Stasia,Macklin Eric A.,Veenstra-VanderWeele Jeremy

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Developmental and Educational Psychology

Reference24 articles.

1. Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, efforts and subject characteristics, and empirical classification;Lecavalier;Autism Dev Disord,2006

2. Aggression in children and adolescents with ASD: Prevalence and risk factors;Kanne;J Autism Dev Disord,2011

3. Use of psychotropic medication in children and adolescents with autism spectrum disorder;Coury;Pediatrics,2012

4. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data;Martin;Am J Psychiatry,2004

5. Acute and long-term safety and tolerability of risperidone in children with autism;Aman;J Child Adolesc Psychopharmacol,2005

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Olanzapine, risperidone and ziprasidone differently affect lysosomal function and autophagy, reflecting their different metabolic risk in patients;Translational Psychiatry;2024-01-08

2. Psychotropic Drug–Related Weight Gain and Its Treatment;American Journal of Psychiatry;2024-01-01

3. Neurodevelopmental Disorders: Autism Spectrum Disorder;Tasman’s Psychiatry;2024

4. Activation of the PERK-CHOP signaling pathway during endoplasmic reticulum stress contributes to olanzapine-induced dyslipidemia;Acta Pharmacologica Sinica;2023-10-25

5. Neurodevelopmental Disorders: Autism Spectrum Disorder;Tasman’s Psychiatry;2023